Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration
Frontiers in Oncology · 17.07.2026 · 16
DOI: 10.3389/fonc.2026.1872192 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Oncology, online erschienen am 17.07.2026. Verfasst von Irina Vergalasova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Cancer Institute, Department of Radiation Oncology, New Brunswick, NJ, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers Cancer Institute, Department of Radiation Oncology, New Brunswick, NJ, United States.
- Jiangxi Cancer Hospital, Nanchang, China.
- Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Hangzhou, China.
- Cancer Screening, Treatment and Support Services MidCentral, Palmerston North, New Zealand.
Zitieren
APA
Vergalasova, I., Jiang, C., Song, T., & Lombe, D. (2026). Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1872192
Vancouver
Vergalasova I, Jiang C, Song T, Lombe D. Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1872192
BibTeX
@article{Vergalasova2026,
author = {Vergalasova, Irina and Jiang, Chunling and Song, Tao and Lombe, Dorothy},
title = {Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1872192}
}
EUVIMED